Enabling Enhanced Cell Health and Function Throughout the Manufacturing Process.
Avectas has built significant flexibility into the single-use assembly (SUA) and is developing the platform such that it can enable several cell therapy manufacturing unit processes, including activation, transfection, transduction, expansion and harvesting within the SUA. With system closure and automation, the platform is designed to produce engineered cells with unmatched health and functionality.
If you would like to learn more about our expanding capabilities upstream and downstream of our core transfection technologies, please select the Contact Us button above and our team will be happy to set up some time to connect.